Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Metrion to offer ion channel screening services
July 2015
SHARING OPTIONS:

CAMBRIDGE, U.K.—Xention Limited has announced the launch of Metrion Biosciences, a contract screening business that will provide comprehensive, high-quality ion channel services for the pharma and biotech industry. Metrion Biosciences means to launch a new panel of in-vitro cardiac ion channel and human cardiomyocyte assays for better detection of cardiac safety risks in new drugs and market its panel of neurological ion channel assays for companies to profile and de-risk drug candidates.
 
“With global demand for high-quality ion channel assay services growing steadily, we have identified an opportunity to commercialize Xention’s longstanding specialist expertise in ion channel biology,” said Dr. Keith McCullagh, chairman of Xention. “Xention was one of the pioneers of automated patch clamp electrophysiology, and our deep experience of this field has enabled the company to collaborate in ion channel research with a number of international pharmaceutical businesses while at the same time developing a portfolio of potential breakthrough drugs for the treatment of atrial fibrillation.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.